Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drugs

Showing results (951-960 of 7,076) with videos related to

Pageof 708
Sort By:
Drugs|August 1, 1995
Therapeutic options in ocular allergic diseaseM Hingorani, S Lightman
Drugs|August 1, 1995
Deflazacort. A review of its pharmacological properties and therapeutic efficacyA Markham, H M Bryson
Drugs|August 1, 1995
Gestodene. A review of its pharmacology, efficacy and tolerability in combined contraceptive preparationsM I Wilde, J A Balfour
Drugs|September 1, 1995
Approaches to meeting the criteria for fixed dose antihypertensive combinations. Focus on metoprololM J Kendall
Drugs|October 1, 1995
Growth hormone secretagogues. Clinical experience and therapeutic potentialZ Laron
Drugs|October 1, 1995
Drug management of noninfective complications of cystic fibrosisI Sanchez, E Guiraldes
Drugs|December 1, 1995
Current guidelines for the eradication of Helicobacter pylori in peptic ulcer diseaseE A Rauws, R W van der Hulst
Drugs|June 1, 1996
Adverse effects of antipsychotic agents. Do newer agents offer advantages?D G Owens
Drugs|June 1, 1996
The thrombocytopenic purpuras. Recognition and managementS Gillis
Drugs|June 1, 1996
Gemfibrozil. A reappraisal of its pharmacological properties and place in the management of dyslipidaemiaC M Spencer, L B Barradell
Pageof 708

Showing results (951-960 of 7,076) with videos related to

Sort By:
Pageof 708
Drugs|August 1, 1995
Therapeutic options in ocular allergic diseaseM Hingorani, S Lightman
Drugs|August 1, 1995
Deflazacort. A review of its pharmacological properties and therapeutic efficacyA Markham, H M Bryson
Drugs|August 1, 1995
Gestodene. A review of its pharmacology, efficacy and tolerability in combined contraceptive preparationsM I Wilde, J A Balfour
Drugs|September 1, 1995
Approaches to meeting the criteria for fixed dose antihypertensive combinations. Focus on metoprololM J Kendall
Drugs|October 1, 1995
Growth hormone secretagogues. Clinical experience and therapeutic potentialZ Laron
Drugs|October 1, 1995
Drug management of noninfective complications of cystic fibrosisI Sanchez, E Guiraldes
Drugs|December 1, 1995
Current guidelines for the eradication of Helicobacter pylori in peptic ulcer diseaseE A Rauws, R W van der Hulst
Drugs|June 1, 1996
Adverse effects of antipsychotic agents. Do newer agents offer advantages?D G Owens
Drugs|June 1, 1996
The thrombocytopenic purpuras. Recognition and managementS Gillis
Drugs|June 1, 1996
Gemfibrozil. A reappraisal of its pharmacological properties and place in the management of dyslipidaemiaC M Spencer, L B Barradell
Pageof 708